Archangels’ investee company, Fios Genomics (“Fios”), which helps pharmaceutical and biotech companies to analyse the large amounts of data generated during drug development, has announced a strategic partnership with one of the world’s largest contract research organisations, Charles River Laboratories, (“Charles River”).
Through this partnership, Charles River clients worldwide will have access to Fios’ expertise in bioinformatics, statistics and biology, to assist in the sourcing and analysis of the big data associated with drug development.
Read more HERE.
